Aequus Pharmaceuticals Inc (AQS) — Capital Reinvestment Ratio

Latest as of June 2020: 1.32x

Aequus Pharmaceuticals Inc (AQS) has a Capital Reinvestment Ratio of 1.32x as of June 2020, meaning it reinvests 1% of its operating cash flow (CA$9.36K) in capital expenditures (CA$12.32K). See Aequus Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.32x

Capex / Operating Cash Flow

Operating Cash Flow

CA$9.36K

CAD

Capital Expenditures

CA$12.32K

CAD

Data as of

Jun 2020

Most recent filing

Annual Capital Reinvestment Ratio for Aequus Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Aequus Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see AQS company net worth.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow